PTEN and prostate carcinoma: Meanwhile, in prostate cancer, the loss-of-function phosphatase and tensin homolog (PTEN) can activate the PI3K/Akt pathway and lead to the accumulation of CEs as a result of excess intracellular cholesterol levels after upregulation of LDLR-mediated cholesterol influx [68].